MBL Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
MBL Wealth's PFE Position: Q2 2026 in Review
MBL Wealth increased its Pfizer (PFE) stake by 19% in Q2 2026, buying an estimated $86.6K and bringing the position to 21,003 shares worth $506K. The position accounts for 0.03% of the portfolio, ranked #211.
MBL Wealth first reported a position in PFE in Q4 2020 and has held it in 18 quarters since. The position peaked at $632K in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- MBL Wealth held 21,003 shares of Pfizer worth $506K as of Q2 2026.
- MBL Wealth bought 3,310 Pfizer shares in Q2 2026, an estimated $86.6K.
- Pfizer made up 0.03% of MBL Wealth's portfolio in Q2 2026, its #211 holding.
- MBL Wealth first reported a position in Pfizer in Q4 2020 and has held it in 18 quarters since.
- MBL Wealth's Pfizer position peaked at $632K in Q4 2022.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.